CONTAINER
CLOSURE INTEGRITY
TESTING
Container closure integrity testing (CCIT) refers to the process of evaluating the tightness and sealing effectiveness of packaging systems, specifically containers, to ensure that the contents inside remain protected and unadulterated. The CCIT testing process is critical in the pharmaceutical industry, among others. Where product safety and efficacy are of the utmost importance.
Challenges in container closure integrity testing
CCI testing plays a critical role in ensuring safety and quality of products packaged in containers. However, container closure integrity testing comes with its own set of challenges, including:
- Detection of small leaks: Containers, especially those used in pharmaceutical and healthcare industries, need to be tightly sealed to prevent any leakage. However, detecting small leaks can be challenging because they may be difficult to identify visually or may result in immediate observable changes. This is where specialized non-destructive cci testing methods are crucial to identify even the smallest leaks.
- Variability in container types and closure systems: Different containers, such as glass vials, ampoules, and plastic bottles, have varying properties and closure systems. Each container type requires tailored testing approaches to ensure proper container closure integrity.
- Impact of product characteristics: The nature of the product itself can pose challenges in container closure integrity testing. For example, products with volatile compounds or gases can affect the accuracy of leak detection methods. It is important to consider the characteristics of the product being tested and select appropriate testing methods that account for such factors.
- Non-destructive testing requirements: Some industries, such as pharmaceuticals, prefer non-destructive leak detection methods to ensure containers can still be used or sold after testing.
The importance of closure integrity testing
The importance of container closure integrity testing has increased in recent years as a result of increasing regulatory requirements and consumer demand for safe and effective products. The US Food and Drug Administration (FDA) has been actively promoting the use of CCIT testing as a quality control tool in the pharmaceutical industry. Because ccit in pharma poses challenges, finding the right leak detection method for your container packaging is crucial.
CCIT testing by vacuum decay method
There are several methods used for container closure integrity testing, for example vacuum decay testing. Oxipack uses the vacuum decay method with CCIT testing. The vacuum decay method works by applying a vacuum to the container and then measuring the rate of pressure change. The following are some benefits of using this method and the specially designed Oxipack Container Closure Integrity Tester:
- High sensitivity: The vacuum decay method is highly sensitive and can detect even small leaks in containers that could cause product contamination. This makes it an ideal method for ensuring the tightness and sealing effectiveness of containers, especially in industries where product safety is of utmost importance, such as pharmaceuticals and medical devices.
- Non-destructive: The vacuum decay method is non-destructive, meaning that containers are not damaged or altered during the testing process. This allows for containers to be re-used or sold after testing, reducing waste and costs.
- Easy to use: The method and CCIT tester are relatively simple to use. To initiate the testing process, the packaging should be inserted into the machine, after which the green button must be pressed. The resulting illumination of either a green or red light will indicate whether the package has passed the test and has been approved, or has failed due to the detection of a leak. It makes it accessible for companies of all sizes to implement this machine. Oxipack will teach you how to use the machine, and you are not required to have specialized knowledge to operate it.
- For multiple sizes: The vacuum decay method and Oxipack leak testers can be used on a variety of container types and shapes, including glass and plastic containers.
- Cost-effective: This methodology entails a higher initial acquisition cost, yet its cost-effectiveness can be achieved within a year of implementation due to the absence of supplementary testing expenses, a characteristic not shared by other (destructive) testing methods.
- Receive quick results: The vacuum decay method provides quick results, making it possible to quickly identify and correct any issues with container tightness and sealing. This helps to minimize product waste and reduce the risk of product contamination.
CONTAINER CLOSURE INTEGRITY TESTING USP
The United States Pharmacopeia (USP) has established guidelines for container closure integrity testing in the pharmaceutical industry. USP <1207> outlines the requirements for performing CCIT testing, including the selection of appropriate testing methods, the frequency of testing, and the interpretation of test results. The USP also provides guidance on the types of containers that should be tested, including glass and plastic containers, as well as the parameters that should be considered when designing a CCIT testing program, such as the size and shape of the container, the type of closure, and the product inside.
Oxipack has developed the Container Closure Integrity Tester to the leak detection needs and requirements within the pharmaceutical industry. The leak tester is able to detect leaks in vials, ampoules and bottles.
Container Closure Integrity Tester
In addition to the guidelines provided by the United States Pharmacopeia (USP), there are other recognized standards and guidelines related to container closure integrity testing (CCIT). It is important for companies in the pharmaceutical industry to stay informed about these standards and guidelines and assess their applicability to their specific products, regions, and regulatory requirements. Incorporating relevant standards into CCIT testing programs can help ensure compliance, improve product safety, and enhance the overall quality control measures.
Some of the other recognized standards and guidelines related to CCIT in pharma include European Pharmacopoeia (Ph. Eur.), International Organization for Standardization (ISO), Parenteral Drug Association (PDA), and Good Manufacturing Practice (GMP).
Container Closure Integrity Tester of Oxipack
Container closure integrity testing is a critical step in ensuring the safety and efficacy of products packaged in containers. CCIT testing is used to evaluate the leak proofness and effectiveness of containers to prevent product contamination and ensure product quality. The USP and other recognized standards are providing guidelines for performing CCIT testing in the pharmaceutical industry and is an important resource for companies looking to establish a container closure integrity testing program. By investing in the Oxipack CCIT tester, we can help companies to protect their customers and maintain the trust and confidence they have built with them.
Contact us for more information about CCIT testing and we would be happy to look at the possibilities together. Fill in the contact form below.